Optimizing Cell Potency, Safety & Viability with Robust
Analytical Packages

Enhance Product Characterization, Method Validation & Release Testing with Novel Immunophenotype, Molecular & Cell-Based Assays to Drive Clinical Development & Gain Regulatory Approval

With robust, reliable and regulatory-ready analytics lying at the heart of clinically successful cell therapies, now is the time to elevate your current workflows and strategies to prepare for clinical and commercial readiness.

Remaining the industry’s leading forum for cell therapy analytical, quality control, assay, and CMC professionals, the 7th Cell Therapy Analytical Development Summit will delve into cutting-edge technologies and proven strategies to aid you in demonstrating product safety, functionality, and quality before heading to market.

Focus your learning and address your specific needs with our refined two-track format, covering early- to late-stage assay development. No matter where you are in the product development cycle, gain hands-on expertise from designing predictive potency assays, through to validating and transferring methods for late-phase trials.

Featuring first-hand case studies and experiences from Takeda, Arsenal Bio, Bayer, Genentech, Adicet Bio, Quell Therapeutics, and the National Institute of Health, seize the opportunity to benchmark against peers, exchange solutions to persistent challenges, and strengthen your analytical toolkit, to excel in an increasingly competitive cell therapy landscape.

I look forward to engaging with my colleagues and identifying the common challenges we are all facing. Recognizing common approaches and sharing best practices is how the field of cell therapy succeeds together

Principal Quality Engineer, Avobis Bio, 2025 Speaker

Avobis Bio - 7th Cell Therapy Analytical Development

Access the Full Event Guide – Your All-in-One Resource for the 2025 Meeting!

• 25+ industry-leading speakers from top pharma, biotech and academia

• 2 dedicated tracks of content, spanning each phase of cell therapy development

• An ASCP/ACP and CMLE-accredited workshop

• Real-world expertise from recent FDA leadership and regulatory bodies

The World-Class Speaker Faculty:

Who Could You Meet?

2seventybio
Dana-Farber
Johnson&Johnson
Novartis
Roche
Fate
Affini-T
Blue Rock
Regeneron
Tr1x Therapeutics

Proud to Partner With:

Lead Partner

Miltenyi
Lead Partner

Official Partners

Agilent
Expertise Partner
bioMerieux
Hosting Partner
LumaCyte
Program Partner
Accellix
Program Partner
Immudex
Innovation Partner
Mission Bio
Innovation Partner
Advanced Instruments
Event Partner
SuperNova FlowCytometry
Event Partner

Hear It from the Experts:

Multiple speakers used case studies as conversation starters which made discussions extremely productive and encouraged more people to share their own company's work

Cell Therapy & Viral Vector Analytical Development Scientist, Adicet Bio, 2024 Attendee

Adicet Bio - 7th Cell Therapy Analytical Development

This meeting was very insightful and provided plenty of learning opportunities from those sharing similar issues, in particular potency and regulatory compliance

Principal Scientist, Arsenal Bio, 2024 Attendee

Arsenal Bio - 7th Cell Therapy Analytical Development